Physiologic performance with uncompromised size and longevity.

The world’s smallest dual-chamber pacemaker designed for maximal device longevity.
REPLY-DR_MicroPort_2018

Featuring

SafeR™

Dramatically reduces unnecessary RV pacing in all pacemaker patients, including AV block patients.

The world’s smallest dual-chamber pacemaker designed for maximal device longevity.

Comprehensive suite of physiologic features available in every Reply DR.

 

SafeR™

Provides AAI pacing while continuously monitoring for AV block. Ensures DDDR pacing when needed and switches back to AAI when possible. SafeR is proven to be safe and effective for all patients with bradyarrhythmia.1,2

 

WARAD

WARAD (Window of Atrial Rate Acceleration Detection) enables patients to benefit from dual-chamber pacing while preventing inappropriate tracking of atrial tachycardias.

 

DPlus

DPlus,  a dual-chamber pacing algorithm with AV search hysteresis, promotes intrinsic conduction without missing a beat.

 

Acceleration

Identifies a sudden drop in cardiac rate for the treatment of vasovagal syndrome and carotid sinus syndrome.

 

Twin Trace

Twin Trace combines an accelerometer and a minute ventilation sensor to provide rate response closest to sinus rhythm.

 

 

This product may not be for sale in your country or your area. For further information on product availability, please contact your local representative.

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For indications, contraindications, precautions and warnings for each device, please refer to the product manual.

Related products:
Orchestra Plus programmer

References

  1. Stockburger M, et al. Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity-a substudy of the ANSWER trial. Europace 2016;18:739–46.
  2. Stockburger M, et al. Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in general population (ANSWER study). Eur Heart J. 2015;36:151–57.
Exemplary message

By continuing to browse this website you confirm that you are a healthcare professional.